Prevalence of exocrine pancreatic insufficiency in patients with chronic pancreatitis without follow-up. PANCR-EVOL Study.
Por:
Marra-Lopez Valenciano C, Bolado Concejo F, Marín Serrano E, Millastre Bocos J, Martínez-Moneo E, Pérez Rodríguez E, Francisco González M, Del Pozo-García A, Hernández Martín A, Labrador Barba E, Orera Pena ML and De madaria E
Publicada:
1 feb 2018
Ahead of Print:
18 sep 2017
Resumen:
Exocrine pancreatic insufficiency (EPI) is an important complication of chronic pancreatitis (CP). Guidelines recommend to rule out EPI in CP, to detect those patients who would benefit from pancreatic enzyme replacement therapy. The aim of this study was to evaluate the prevalence of EPI in patients with CP without follow-up in the last 2 years and to describe their nutritional status and quality of life (QoL).
Filiaciones:
Marra-Lopez Valenciano C:
Digestive Service, Complejo Hospitalario de Navarra, Pamplona, Spain
Digestive Service, Hospital Universitario Araba, Álava, Spain
Bolado Concejo F:
Digestive Service, Complejo Hospitalario de Navarra, Pamplona, Spain
Marín Serrano E:
Digestive Service, H. La Paz, Madrid, Spain
Millastre Bocos J:
Digestive Service, H. Universitario Miguel Servet, Zaragoza, Spain
Martínez-Moneo E:
Digestive Service, H. Universitario de Cruces, Vizcaya, Spain
Pérez Rodríguez E:
Digestive Service, H. Universitario Reina Sofia, Córdoba, Spain
Francisco González M:
Digestive Service, Complejo Hospitalario Universitario de Orense, Orense, Spain
Del Pozo-García A:
Digestive Service, H. 12 de Octubre, Madrid, Spain
Hernández Martín A:
Digestive Service, H. San Eloy, Vizcaya, Spain
Labrador Barba E:
Medical Department Mylan, Spain
Orera Pena ML:
Medical Department Mylan, Spain
De madaria E:
Department of Gastroenterology, H. General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL - Fundación FISABIO), Alicante, Spain
|